Proceedings of the National Academy of Sciences · 2017 · 72 citations · 37 references
Life SciencesImmunologyOncologyCancer ImmunologyCellular ImmunologyTumor ImmunologyAntitumor T Cell ResponsesBreast Cancer OncologyImmune Repertoire FormationT Cell BiologyT Cell Responses To TumorsTumor-infiltrating LymphocytesClonal Population StructureImmune Signature ProfilingT Cell Receptor SequencingT-cell Receptor ClonalityT-cell Receptor Repertoire DiversityT-cell Repertoire AnalysisT-cell Responses To Tumor AntigensTumor-specific T Cell Clones
Tumor-infiltrating T cells play an important role in many cancers, and can improve prognosis and yield therapeutic targets. We characterized T cells infiltrating both breast cancer tumors and the surrounding normal breast tissue to identify T cells specific to each, as well as their abundance in peripheral blood. Using immune profiling of the T cell beta-chain repertoire in 16 patients with early-stage breast cancer, we show that the clonal structure of the tumor is significantly different from adjacent breast tissue, with the tumor containing ∼2.5-fold greater density of T cells and higher clonality compared with normal breast. The clonal structure of T cells in blood and normal breast is more similar than between blood and tumor, and could be used to distinguish tumor from normal breast tissue in 14 of 16 patients. Many T cell sequences overlap between tissue and blood from the same patient, including ∼50% of T cells between tumor and normal breast. Both tumor and normal breast contain high-abundance "enriched" sequences that are absent or of low abundance in the other tissue. Many of these T cells are either not detected or detected with very low frequency in the blood, suggesting the existence of separate compartments of T cells in both tumor and normal breast. Enriched T cell sequences are typically unique to each patient, but a subset is shared between many different patients. We show that many of these are commonly generated sequences, and thus unlikely to play an important role in the tumor microenvironment.
37
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
Nicholas McGranahan, Andrew J.S. Furness, Rachel Rosenthal et al. · Science · 2016 · 3.1K citations · Full text
Life Sciences, Immunology, Oncology +17
Cancer Immunotherapy Based on Mutation-Specific CD4+ T Cells in a Patient with Epithelial Cancer
Eric Tran, Simon Turcotte, Alena Gros et al. · Science · 2014 · 1.7K citations · Full text
Life Sciences, Immunology, Oncology +17
Mutant MHC class II epitopes drive therapeutic immune responses to cancer
Sebastian Kreiter, Mathias Vormehr, Niels van de Roemer et al. · Nature · 2015 · 1.2K citations · Full text
Life Sciences, Immunology, Oncology +14
Comprehensive assessment of T-cell receptor β-chain diversity in αβ T cells
Harlan Robins, Paulo Vidal Campregher, Santosh K. Srivastava et al. · Blood · 2009 · 1.2K citations · Full text